Fulcrum Therapeutics, Inc. (FULC)
NASDAQ·Healthcare·Biotechnology
$3.52
+1.73%
Mkt Cap $199.67M
Analyst Ratings
Buy
0
Hold
3
Sell
2
Price Target (26 analysts)
$20.67
Range $10.00 – $25.00
Implied Upside
+487.2%
Consensus $20.67 vs current $3.52
NASDAQ·Healthcare·Biotechnology
$3.52
+1.73%
Mkt Cap $199.67M
Buy
0
Hold
3
Sell
2
Price Target (26 analysts)
$20.67
Range $10.00 – $25.00
+487.2%
Consensus $20.67 vs current $3.52